Mark Paine
Impact in
-
- Multiple Sclerosis Research Studies
- Ophthalmology top 2%
- Retinal and Optic Conditions
- Ocular Diseases and Behçet’s Syndrome
- Glaucoma and retinal disorders
Papers in
-
- Multiple Sclerosis Research Studies 24
-
- Glaucoma and retinal disorders 4
- Retinal and Optic Conditions 4
- Co-authors
- Justin O’Day (7 shared papers)Alexander I. Klistorner (7 shared papers)Jessica Vitkovic (3 shared papers)Hemamalini Arvind (4 shared papers)Stuart L. Graham (4 shared papers)Con Yiannikas (4 shared papers)Raymond Garrick (3 shared papers)John Grigg (3 shared papers)
- Journals
- Multiple Sclerosis Journal (5 papers)Clinical and Experimental Ophthalmology (4 papers)PLoS ONE (3 papers)Audiology and Neurotology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Mark Paine
47 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 122
- Pathology and Forensic Medicine 892
- Ophthalmology 319
- Neurology 216
- Neurology 310
- Rheumatology 111
Countries citing papers authored by Mark Paine
This map shows the geographic impact of Mark Paine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Paine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Paine more than expected).
Fields of papers citing papers by Mark Paine
This network shows the impact of papers produced by Mark Paine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Paine. The network helps show where Mark Paine may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Paine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 154 | |
| 2 | 2008 | 138 | |
| 3 | 2011 | 124 | |
| 4 | 2013 | 123 | |
| 5 | 2016 | 99 | |
| 6 | 2003 | 94 | |
| 7 | 2014 | 87 | |
| 8 | 2009 | 83 | |
| 9 | 2005 | 79 | |
| 10 | 2014 | 74 | |
| 11 | 2010 | 70 | |
| 12 | 2013 | 64 | |
| 13 | 2000 | 58 | |
| 14 | 2007 | 55 | |
| 15 | 2016 | 55 | |
| 16 | 2001 | 51 | |
| 17 | 2017 | 45 | |
| 18 | 2013 | 42 | |
| 19 | 2011 | 40 | |
| 20 | 2010 | 36 |
About Mark Paine
Mark Paine is a scholar working on Pathology and Forensic Medicine, Ophthalmology, Neurology, Neurology and Sensory Systems, having authored 47 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (24 papers), Vestibular and auditory disorders (5 papers), Glaucoma and retinal disorders (4 papers), Retinal and Optic Conditions (4 papers), Hearing, Cochlea, Tinnitus, Genetics (3 papers), Cerebral Venous Sinus Thrombosis (3 papers), Vasculitis and related conditions (2 papers) and Acute Ischemic Stroke Management (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (892 citations), Ophthalmology (319 citations), Neurology (216 citations), Neurology (310 citations) and Rheumatology (111 citations). Mark Paine has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Justin O’Day, Alexander I. Klistorner, Jessica Vitkovic, Hemamalini Arvind, Stuart L. Graham, Con Yiannikas, Raymond Garrick, John Grigg, Gary Rance and Colin C. K. Chan. Their work appears in journals such as Multiple Sclerosis Journal, Clinical and Experimental Ophthalmology, PLoS ONE, Audiology and Neurotology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.